After losing some value lately, a hammer chart pattern has been formed for Veru (VERU), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, ...

Latest data shows the largest indicative borrow rate increases among liquid option names include: Oatly Group AB (OTLY) 161.49% +5.22, Energy ...

China’s Harbour BioMed has launched a new biotech to develop bispecific antibodies focused on the holy grail of next-gen ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

A downtrend has been apparent in Veru Inc. (VERU) lately with too much selling pressure. The stock has declined 9.2% over the past four weeks. However, given the fact that it is now in oversold ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Veru Veru’s oral drug, enobosarm, targets the androgen hormones that play a role in body development and reproductive health. In a mid-stage study, patients who received the drug along with Wegovy ...

$VERU insiders have traded $VERU stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...

Veru Inc. (NASDAQ:VERU – Get Free Report) was the recipient of a large increase in short interest in the month of January.As of January 31st, there was short interest totalling 14,620,000 shares ...

Veru Inc (NASDAQ:VERU) reported positive top-line results from its Phase 2B clinical study for Novosarm, showing significant preservation of lean body mass in older patients. The company successfully ...